UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
O96175 (P230P_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Male gametocyte surface protein P230p; | |
P86148 (RH1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Reticulocyte-binding protein homolog 1; Normocyte-binding protein 1; Reticulocyte-binding protein homolog 1 240 kDa form; Reticulocyte-binding protein homolog 1 120 kDa form; | |
Q8IDX6 (RH2A_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Reticulocyte-binding protein homolog 2a; Reticulocyte-binding protein homolog 2a 85 kDa form; Reticulocyte-binding protein homolog 2a 285 kDa form; | |
C0H5F4 (RH2B_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Reticulocyte-binding protein homolog 2b; Reticulocyte-binding protein homolog 2b 85 kDa form; Reticulocyte-binding protein homolog 2b 297 kDa form; | |
Q8I1N6 (AP2A_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | AP2/ERF domain-containing protein PFD0985w; | |
Q8IHY1 (GCYA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Guanylate cyclase alpha; Guanylyl cyclase; | |
Q8IDA0 (GCYB_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Guanylate cyclase beta; Guanylyl cyclase beta; | |
O97239 (DOP1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Protein DOP1 homolog PFC0245c; | |
Q8IBG1 (DYHC1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Dynein heavy chain-like protein 1; | |
C6KSS5 (LRR2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Protein PFF0380w; | |
O77384 (LRR4_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Protein PFC0760c; | |
C6KTD2 (SET1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Putative histone-lysine N-methyltransferase 1; | |
Q8IE95 (SETVS_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Variant-silencing SET domain-containing protein; SET domain-containing protein 2; | |
C6KT50 (PDX1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Pyridoxal 5'-phosphate synthase subunit Pdx1; | |
Q8IHZ9 (KC1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Casein kinase I; Casein kinase 1; | |
O97336 (EPTP7_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | EMP1 trafficking protein-7; | |
O77389 (FNT_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Formate-nitrite transporter; Lactate/H(+) symporter; Lactate/H(+) transporter; | |
Q8IID4 (DYHC2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Dynein heavy chain-like protein 2; | |
Q8I423 (PF38_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Merozoite surface protein P38; | |
Q8ILI6 (AN32_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Acidic leucine-rich nuclear phosphoprotein 32-related protein; ANP32/acidic nuclear phosphoprotein-like protein; | |
Q8ILW0 (SUFC_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Iron-sulfur cluster assembly protein SufC; | |
P61075 (CDK2H_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Cyclin-dependent kinase 2 homolog; Cell division control protein 2 homolog; Protein kinase 5; cdc2-related kinase 2; | |
Q8IKN4 (NNRE_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | NAD(P)H-hydrate epimerase; NAD(P)HX epimerase; | |
Q8IHS4 (CCD1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Coiled-coil domain-containing protein PF3D7_1144200; | |
Q8IBH7 (IF2A_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Eukaryotic translation initiation factor 2 subunit 1; Eukaryotic translation initiation factor 2 subunit alpha; | |
Q8IIG1 (YK213_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PF3D7_1120600; | |
O96185 (YPF08_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PF3D7_0210200; | |
Q8IBP1 (YPF16_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized membrane protein; | |
Q8ILR9 (YPF17_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Protein PF3D7_1417600; | |
Q8I4T1 (VPS26_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Vacuolar protein sorting-associated protein 26; | |
Q8I4V8 (FKB35_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Peptidyl-prolyl cis-trans isomerase FKBP35; PfFKBP35; | |
Q8I384 (ARGI_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Arginase; | |
Q8I1T1 (KAD3_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | GTP:AMP phosphotransferase; | |
Q8IL52 (YSNF1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Putative vacuolar protein sorting-associated protein 60; | |
Q8ILW6 (NMT_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Glycylpeptide N-tetradecanoyltransferase; Myristoyl-CoA:protein N-myristoyltransferase; N-myristoyltransferase; | |
Q25820 (EFTU_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Elongation factor Tu, apicoplast; | |
Q8IEG9 (LIPLA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Lipoate--protein ligase 1; | |
Q8IIK4 (PDX2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Pyridoxal 5'-phosphate synthase subunit PDX2; Pyridoxal 5'-phosphate synthase glutaminase subunit; | |
Q8ILC2 (TGTL_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Queuine tRNA-ribosyltransferase-like protein; | |
Q8IKM8 (UCHL3_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Ubiquitin carboxyl-terminal hydrolase UCHL3; PfUCHL3; | |
Q7K740 (CSP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Circumsporozoite protein; Circumsporozoite protein C-terminus; | |
Q8I2X3 (GAP50_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Glideosome-associated protein 50; Secreted acid phosphatase; | |
P62368 (ISPF_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase, apicoplast; PfIspF; | |
Q76NM7 (RAB5B_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Ras-related protein Rab-5B; | |
Q8IDM6 (ENT1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Nucleoside transporter 1; Equilibrative nucleoside transporter 1; Equilibrative nucleoside transporter type 1; | |
Q8IDQ0 (LIPA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Lipoyl synthase, apicoplast; Lipoate synthase; Lipoic acid synthase; | |
Q8IE47 (SIR2A_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | NAD-dependent protein deacylase Sir2A; PfSir2; PfSir2A; Regulatory protein SIR2 homolog A; | |
C6KST8 (ZIP1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Zinc transporter ZIP1; | |
Q8I4V2 (RBM22_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Pre-mRNA-splicing factor RBM22 homolog; | |
Q8IL06 (YPF07_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Uncharacterized protein PF3D7_1446700; |
Plasmodium falciparum is a protozoan parasite that resides in human red blood cells, but can also infect the brain and liver. P. falciparum is one of the species of Plasmodium that causes malaria in humans. It has a complex life-cycle requiring both human and female Anopheles mosquito. P. falciparum is responsible for the disease's most dangerous form, malignant or falciparum malaria, which has the highest complication rates and mortality.
With more than 200 million cases and 400,000 deaths from malaria worldwide, P. falciparum (causing roughly 50% of the cases) has been the focus of malaria research for decades.
The genome of P. falciparum was first sequenced in 2002.
From left to right: i) The number of proteins in the reference proteome of Plasmodium falciparum, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Plasmodium falciparum for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Plasmodium falciparum, please visit UniProtKB.
You can easily download the latest protein sequences for Plasmodium falciparum proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2025_01 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
5,361 | 3,736 | 6,699 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Plasmodium falciparum reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Plasmodium falciparum proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 10-mer | 12-mer | 14-mer | 16-mer | 20-mer | 24-mer | 40-mer | 60-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6,023 | 479 | 33 | 70 | 10 | 42 | 10 | 5 | 4 | 8 | 3 | 4 | 1 | 3 | 3 | 1 |